查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553476

臨床試驗管理服務市場規模、佔有率、趨勢分析報告：按服務、適應症、按最終用途、按地區、細分市場預測，2024-2030 年

Clinical Trial Management Services Market Size, Share & Trends Analysis Report By Services (Regulatory submissions, Medical Writing), By Indication (Oncology, Diabetes), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10個工作天內

價格

臨床試驗管理服務市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球臨床試驗管理服務市場規模預計將達到 538.5 億美元。

預計2024年至2030年該市場將以8.25%的複合年成長率擴張。臨床試驗活動外包趨勢的增加、先進治療方法研發的活性化以及臨床試驗的全球化是推動市場成長的主要因素。

過去20年來，臨床試驗的數量顯著增加。這背後是對療效提高的新藥不斷成長的需求以及尖端醫療技術的傳播。根據 Clinical Trials.gov 統計，截至 2022 年 4 月，今年的臨床試驗總數已超過 410,903 項，而 2020 年為 325,773 項。

臨床監測、資料管理、現場監測和醫學寫作服務等臨床試驗管理服務具有成本效益且節省時間。它們還可以協調機構之間的臨床資料並降低失敗率。此外，雲端處理、人工智慧（AI）、巨量資料處方、預測分析、醫療物聯網和行動技術等數位技術的整合仍然是一項重大發展。這些技術在提高生產力和加快臨床試驗步伐方面顯示出巨大潛力。

COVID-19大流行對市場產生了重大影響。 COVID-19 的疫情對市場產生了重大影響，為進行臨床試驗和限制現場監測訪問的替代解決方案帶來了意想不到的緊迫性。為了限制 COVID-19 的傳播並同時保持臨床研究的正常運轉，研究人員轉向了遠端臨床試驗監測服務和平台。例如，根據 2020 年佛羅倫薩調查，超過 60% 的臨床試驗中心和臨床試驗申辦者表示，他們對臨床研究遠端現場監測解決方案的接受度超過 50%。

臨床試驗管理服務市場報告亮點

  • 臨床試驗監測領域佔市場主導地位，2023年收益佔有率為27.64%。臨床試驗數量的增加和臨床試驗監測技術的進步是推動成長的主要因素。
  • 腫瘤學領域在2023年佔據市場主導地位，收益佔有率為37.05%，預計在預測期內將以8.45%的最快複合年成長率成長。
  • 醫藥細分市場佔據主導地位，2023 年銷售額佔有率為 38.96%。這很大程度得益於過去二十年不斷增加的研發投入和新藥的開發。
  • 北美臨床試驗管理服務市場在2023年以34.96%的最大收益佔有率佔據全球主導地位。對新治療方法和藥物的需求導致該全部區域臨床試驗的激增。
  • 預計亞太地區臨床試驗管理服務市場在預測期內將以最快的複合年成長率成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章臨床試驗管理服務市場的變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 配套市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 臨床試驗管理服務市場：分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章 臨床試驗管理服務市場：按服務分類的估計和趨勢分析

  • 細分儀表板
  • 全球臨床試驗管理服務市場，按服務分類的差異分析
  • 2018-2030年全球臨床試驗管理服務市場規模及趨勢分析（按服務）
  • 臨床試驗監測
  • 監理意見書
  • 臨床試驗資料管理
  • 醫學寫作
  • 現場管理
  • 計劃管理
  • 其他

第5章 臨床試驗管理服務市場：按適應症估計與趨勢分析

  • 細分儀表板
  • 全球臨床試驗管理服務市場，依適應症的變異分析
  • 2018-2030年全球臨床試驗管理服務市場規模與趨勢分析（依適應症）
  • 自體免疫/發炎
  • 疼痛管理
  • 腫瘤學
  • 中樞神經系統症狀
  • 糖尿病
  • 肥胖
  • 心血管
  • 其他

第6章 臨床試驗管理服務市場：依最終用途分類的估計與趨勢分析

  • 細分儀表板
  • 全球臨床試驗管理服務市場，依最終用途分類的變異分析
  • 2018-2030 年全球臨床試驗管理服務市場規模與趨勢分析（依最終用途）
  • 藥品
  • 生物製藥
  • 醫療設備

第7章 臨床試驗管理服務市場：區域估計與趨勢分析

  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 2018 年至 2030 年市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018 年至 2030 年市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018 年至 2030 年市場估計與預測
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 2018 年至 2030 年市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018 年至 2030 年市場估計與預測
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
    • 市場領導者
    • 新興玩家
  • 服務熱力圖分析（玩家間比較分析）
  • 公司簡介
    • CTI Clinical Trial &Consulting
    • Charles River Laboratories
    • Medpace Holdings, Inc.
    • Wuxi Apptec
    • SGS Societe Generale de Surveillance SA
    • Laboratory Corporation of America Holdings
    • IQVIA, Inc.
    • Syneous Health
    • Atlantic Research Group
    • ICON Plc
Product Code: GVR-4-68039-993-8

Clinical Trial Management Services Market Growth & Trends:

The global clinical trial management services market size is anticipated to reach USD 53.85 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.25% from 2024 to 2030. The increasing trend of outsourcing clinical trial activities, the rise in research and development of advanced therapies, and the globalization of clinical trials are a few key factors driving the growth of the market.

The number of clinical trials has significantly increased in the past two decades. This is due to the rising need for novel pharmaceutical products with improved efficacy as well as the increasing penetration of cutting-edge medical technologies. According to Clinical trials.gov, the total number of clinical trials accounted for 325,773 in 2020, whereas, as of April 2022, the number of clinical trials this year totaled more than 410,903.

Clinical trial management services such as clinical monitoring, data management, site monitoring, and medical writing service are cost-effective and time-saving. These also harmonize clinical data across sites and failure rates. Furthermore, the integration of digital technologies, including cloud computing, Artificial Intelligence (AI), big data prescriptive, and predictive analytics, the Internet of Medical Things, and mobile technology remain major developments on the horizon. These technologies have shown great promise in improving productivity while accelerating the pace of clinical trials.

The COVID-19 pandemic significantly impacted the market. It created an unexpected urgency for alternative solutions to clinical trial execution, limiting on-site monitoring visits. It prompted researchers to use remote clinical trial monitoring services and platforms to reduce the spread of the COVID-19 infection as well as to simultaneously function in clinical research. For instance, according to the Florence survey in 2020, more than 60% of clinical study sites and clinical trial sponsors stated more than 50% acceptance of remote site monitoring solutions for clinical research.

Clinical Trial Management Services Market Report Highlights:

  • The clinical trial monitoring segment dominated the market with a revenue share of 27.64% in 2023. The rising number of clinical trials and technological advancements in trial monitoring are key factors driving the growth.
  • The oncology segment dominated the market with a revenue share of 37.05% in 2023 and is expected to grow at the fastest CAGR of 8.45% during the forecast period.
  • The pharmaceuticals segment dominated the market with a revenue share of 38.96% in 2023. This can be largely attributed to the rise in R&D investments and the development of new drugs over the past two decades.
  • North America clinical trial management services market dominated globally in 2023 with the largest revenue share of 34.96%. The demand for new therapies and drugs has led to a surge in clinical trials across the region.
  • Asia Pacific clinical trial management services market is expected to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Region Wise Market: Base Estimates
    • 1.5.2. Global Market: CAGR Calculation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis (Model 1)
    • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
    • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
    • 1.6.4. Bottom-Up Approach (Model 4)
  • 1.7. List of Secondary Sources
  • 1.8. List of Abbreviations
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Clinical Trial Management Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing technological advancement in the clinical trial monitoring services
      • 3.2.1.2. Rise in R&D expenditure by pharmaceutical and biopharmaceutical companies
      • 3.2.1.3. Growth in the number of outsourced projects related to clinical trial management services
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with clinical trial management services
      • 3.2.2.2. Stringent regulatory policies for clinical trial management services
  • 3.3. Clinical Trial Management Services Market: Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Management Services Market: Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Clinical Trial Management Services Market, Services Movement Analysis
  • 4.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by Services, 2018 to 2030 (USD Million)
  • 4.4. Clinical Trial Monitoring
    • 4.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.5. Regulatory Submissions
    • 4.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.6. Clinical Trial Data Management
    • 4.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.7. Medical Writing
    • 4.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.8. Site Management
    • 4.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.9. Project Management
    • 4.9.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trial Management Services Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Clinical Trial Management Services Market, Indication Movement Analysis
  • 5.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 5.4. Autoimmune/Inflammation
    • 5.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.5. Pain Management
    • 5.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.7. CNS Conditions
    • 5.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.8. Diabetes
    • 5.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.9. Obesity
    • 5.9.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.10. Cardiovascular
    • 5.10.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trial Management Services Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Clinical Trial Management Services Market, End Use Movement Analysis
  • 6.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceuticals
    • 6.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.5. Biopharmaceuticals
    • 6.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.6. Medical Devices
    • 6.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trial Management Services Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Global Regional Market Snapshot
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Scenario
      • 7.5.8.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Scenario
      • 7.5.9.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.3. Japan
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Scenario
      • 7.6.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Scenario
      • 7.6.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Scenario
      • 7.6.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Scenario
      • 7.6.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Scenario
      • 7.8.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Scenario
      • 7.8.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Scenario
      • 7.8.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Scenario
      • 7.8.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Service Heat Map Analysis (a comparative analysis of the players together)
  • 8.3. Company Profiles
    • 8.3.1. CTI Clinical Trial & Consulting
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Charles River Laboratories
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Medpace Holdings, Inc.
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Wuxi Apptec
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. SGS Societe Generale de Surveillance SA
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Laboratory Corporation of America Holdings
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. IQVIA, Inc.
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Syneous Health
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Atlantic Research Group
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. ICON Plc
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 4 Global Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 5 Global Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Global Clinical Trial Management Services, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 9 North America Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 10 North America Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 12 U.S. Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 13 U.S. Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 15 Canada Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 16 Canada Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Mexico Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 18 Mexico Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 19 Mexico Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 22 Europe Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 23 Europe Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 24 Germany Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 25 Germany Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 26 Germany Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 27 UK Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 28 UK Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 29 UK Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 30 France Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 31 France Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 32 France Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Italy Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 34 Italy Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 35 Italy Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 37 Spain Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 38 Spain Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Denmark Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 40 Denmark Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 41 Denmark Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 43 Sweden Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 44 Sweden Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Norway Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 46 Norway Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 47 Norway Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 52 China Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 53 China Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 54 China Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Japan Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 56 Japan Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 57 Japan Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 58 India Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 59 India Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 60 India Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 61 South Korea Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 62 South Korea Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 63 South Korea Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 64 Australia Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 65 Australia Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 66 Australia Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 68 Thailand Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 69 Thailand Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 72 Latin America Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 73 Latin America Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 75 Brazil Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 76 Brazil Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 78 Argentina Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 79 Argentina Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 85 South Africa Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 86 South Africa Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 90 UAE Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 91 UAE Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 92 UAE Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Clinical Trial Management Services, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Porter's Five Forces Analysis
  • Fig. 10 PESTEL Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Clinical Trial Management Services, for Clinical Trial Monitoring, 2018 - 2030 (USD Million)
  • Fig. 13 Global Clinical Trial Management Services, for Regulatory Submissions, 2018 - 2030 (USD Million)
  • Fig. 14 Global Clinical Trial Management Services, for Clinical Trial Data Management, 2018 - 2030 (USD Million)
  • Fig. 15 Global Clinical Trial Management Services, for Medical Writing, 2018 - 2030 (USD Million)
  • Fig. 16 Global Clinical Trial Management Services, for Site Management, 2018 - 2030 (USD Million)
  • Fig. 17 Global Clinical Trial Management Services, for Project Management, 2018 - 2030 (USD Million)
  • Fig. 18 Global Clinical Trial Management Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 19 Global Clinical Trial Management Services, for Autoimmune/Inflammation, 2018 - 2030 (USD Million)
  • Fig. 20 Global Clinical Trial Management Services, for Pain Management, 2018 - 2030 (USD Million)
  • Fig. 21 Global Clinical Trial Management Services, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 22 Global Clinical Trial Management Services, for CNS Conditions, 2018 - 2030 (USD Million)
  • Fig. 23 Global Clinical Trial Management Services, for Diabetes, 2018 - 2030 (USD Million)
  • Fig. 24 Global Clinical Trial Management Services, for Obesity, 2018 - 2030 (USD Million)
  • Fig. 25 Global Clinical Trial Management Services, for Cardiovascular, 2018 - 2030 (USD Million)
  • Fig. 26 Global Clinical Trial Management Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 27 Global Clinical Trial Management Services, for Pharmaceuticals, 2018 - 2030 (USD Million)
  • Fig. 28 Global Clinical Trial Management Services, for Biopharmaceuticals, 2018 - 2030 (USD Million)
  • Fig. 29 Global Clinical Trial Management Services, for Medical Devices, 2018 - 2030 (USD Million)
  • Fig. 30 Regional Outlook, 2023 & 2030
  • Fig. 31 North America Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 UAE Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)